INFORMED CONSENT
The doctor informs the patient about the benefits and risks of the IndiTreat® test. When agreement to perform the IndiTreat® test is achieved, the Test-Order form can be signed.
TISSUE SAMPLING AND SHIPPING
A tumor sample is typically obtained with a needle biopsy of the patients’ metastases. The tumor tissue is placed in a medium to keep the tumor cells alive and transported to 2cureX laboratory within 24 hours.
PROCESSING THE TUMOR SAMPLE
Hundreds of 3D tumoroids are grown from cell clusters out of the patient tumor.
CONDUCTING INDITREAT® TEST
The patients tumoroids are exposed to different cancer drugs and drug combinations assessing their impact on the tumoroids growth.
EVALUATION AND REPORTING
The sensitivity of the tumoroids to the specific drug panel is measured and compared to a reference panel. An IndiTreat® test report is send to the doctor within 3 weeks.
INDIVIDUALIZED THERAPY CHOICE
Based on the IndiTreat® result and after consideration of all available information on the patient, the doctor decides which treatment she/he will recommend the patient.
